Loading stock data…
Heartflow, Inc. (HTFL)
$47.75-1.16 (-2.37%)
Market ClosedLast close Sep 8
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Heartflow, Inc. in the Healthcare sector is trading at $47.75 with a market capitalization of $2.5B. Wall Street consensus targets $43.50 (8 analysts), implying a -8.9% move over the next 12 months. The stock is currently near its 52-week high of $51.78, remaining 59.5% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -8.9% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $52.59M↑ | $49.13M↑ | $46.28M↑ | $43.42M↑ | $37.20M |
| Gross Profit | $42.16M↑ | $39.06M↑ | $35.41M↑ | $32.78M↑ | $27.94M |
| Operating Income | -$22.02M↓ | -$17.75M↓ | -$15.10M↓ | -$13.71M↑ | -$17.50M |
| Net Income | -$27.38M↓ | -$24.39M↑ | -$50.85M↓ | -$9.20M↑ | -$32.34M |
Peer Comparison
JNJUNHPFE
Fundamentals
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personal...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.49B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-39.14%
Volume
Today's trading volume
2.80M
Recent News
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The medical technology company reported a notable insider sale as its shares delivered a 59% one-year return.
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
The medical technology company reported a notable insider sale as shares returned 35% over the past year.
Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds Stand
Heartflow Inc. (NASDAQ:HTFL) climbed by 46 percent week-on-week, making it the fourth-highest gainer on the stock market last week, thanks to its strong revenue performance that helped bolster its growth outlook for the full-year period. In an updated report during the week, the listed firm said that it grew its revenues by 48 percent in […]
Is HeartFlow (HTFL) Already Overvalued Or Still Worth The Hype?
HeartFlow stock has surged over the past month, yet the valuation checks currently lean expensive rather than pointing to a clear bargain. That mix of strong recent returns and a low value score raises questions about how much optimism is already reflected in the share price. HeartFlow has returned 69.1% over the past month, which sets a high bar for future performance to justify the current valuation. Expectations around continued adoption of HeartFlow's AI platform for diagnosing coronary...
HeartFlow (HTFL) Jumps On Q2 Results As Raised Outlook Leaves Shares Fully Valued
HeartFlow (HTFL) moved after its second quarter 2026 report, which paired higher sales with a continued net loss, along with a raised full year revenue outlook that lifted investor attention on the stock. See our latest analysis for HeartFlow. HeartFlow has seen sharp share price momentum around these results, with a 1 day share price return of 35.7% and a 30 day share price return of 69.1%, helping lift the stock to US$42.08 and contributing to a 35% 1 year total shareholder return. If the...